I. Start the exam by click the “Start” button
Disorders of Platelets and Vessel Wall- Part 4
II. See all quizzes of the Disorders of Platelets and Vessel Wall at here:
Disorders of Platelets and Vessel Wall- Part 1 |Disorders of Platelets and Vessel Wall- Part 2 |Disorders of Platelets and Vessel Wall- Part 3 |Disorders of Platelets and Vessel Wall- Part 4
1. vWD may be acquired in which of the following situations ?
A. Monoclonal gammopathies of undetermined significance
B. Waldenstrom’s macroglobulinemia
C. Multiple myeloma
D. All of the above
2. In which of the following diseases, platelets are deficient or defective in Gp IIb/IIIa complex ?
A. Bernard-Soulier syndrome
B. Glanzmann’s thrombasthenia
C. Hermansky-Pudlak syndrome
D. Chediak-Higashi syndrome
3. In which of the following diseases, platelets have deficiency or dysfunction of the Gp Ib/IX complex ?
A. Bernard-Soulier syndrome
B. Glanzmann’s thrombasthenia
C. Hermansky-Pudlak syndrome
D. Chediak-Higashi syndrome
4. Which of the following is not an autosomal recessive trait ?
A. Bernard-Soulier syndrome
B. Glanzmann’s thrombasthenia
C. von Willebrand’s disease Type II
D. von Willebrand’s disease Type III
5. In Heyde’s syndrome, which of the following is a feature apart from aortic stenosis ?
A. Raynaud’s phenomenon
B. Gastrointestinal bleeding
C. Clubbing
D. Pes cavus
6. Which of the following platelet aggregation agonists require fibrinogen for binding ?
A. Adenosine diphosphate (ADP)
B. Thrombin
C. Epinephrine
D. All of the above
7. In platelet granules, which of the following is “adhesive glycoprotein” ?
A. Thrombospondin
B. Fibronectin
C. vWF
D. All of the above
8. von Willebrand factor gene is located on which chromosome ?
A. 10
B. 11
C. 12
D. 13
9. Most common type of vWD is ?
A. Type 1
B. Type 2A
C. Type 2B
D. Type 3
10. Which of the following vWD is inherited as autosomal recessive trait ?
A. Type 1
B. Type 2A
C. Type 2B
D. Type 3
11. vWF protein levels are lowest in which of the following blood groups ?
A. A
B. B
C. AB
D. O
12. Which of the following is called “severe vWD” ?
A. Type 1
B. Type 2A
C. Type 2B
D. Type 3
13. Which type of vWD reflects mutations in vWF that preclude binding of FVIII ?
A. Type 2A
B. Type 2B
C. Type 2M
D. Type 2N
14. Which type of vWD is termed “autosomal hemophilia” ?
A. Type 2A
B. Type 2B
C. Type 2M
D. Type 2N
15. Acquired vWD is seen most commonly in ?
A. Monoclonal gammopathies of undetermined significance
B. Multiple myeloma
C. Waldenstrom’s macroglobulinemia
D. None of the above
16. Which of the following best relates to Heyde’s syndrome ?
A. Cirrhosis of liver
B. Angiodysplasia of gastrointestinal tract
C. Pancreatic neoplasis
D. Ectopic spleen
17. Which of the following is false in von Willebrand Disease ?
A. Prolonged BT
B. Normal platelet count
C. Increased APTT
D. Decreased plasma vWF concentration
18. Platelet count are modestly reduced in which of the following types of vWD ?
A. Type 1
B. Type 2A
C. Type 2B
D. Type 3
19. What is the nature of “Ristocetin” ?
A. Analgesic
B. Antibiotic
C. Uterine relaxant
D. Digestive enzyme
20. In which of the following vWD, vWF: Ag is normal ?
A. Type 1
B. Type 2A
C. Type 2B
D. Type 3
21. In which of the following vWD, vWF: Ag is normal ?
A. Type 2M
B. Type 2N
C. Type 2B
D. Type 3
22. Desmopressin acts through which of the following vasopressin receptors ?
A. Type 1
B. Type 2
C. Type 3
D. Type 4
.
23. Dose of Desmopressin is ?
A. 0.3 µg / kg body weight IV infusion
B. 3.0 µg / kg body weight IV infusion
C. 30 µg / kg body weight IV infusion
D. 300 µg / kg body weight IV infusion
24. DDAVP, or desmopressin is most effective for treatment of which type of von Willebrand disease ?
A. Type 1
B. Type 2A
C. Type 2B
D. Type 3
25. DDAVP, or desmopressin is not indicated in which type of von Willebrand disease ?
A. Type 1
B. Type 2A
C. Type 2B
D. Type 2M
26. Antifibrinolytic amino acids like Aminocaproic acid or tranexamic acid used in treatment of vWD can cause which of the following complications ?
A. Cholelithiasis
B. Ureteral obstruction
C. Glaucoma
D. Alopecia
27. In type 3 vWD, which of the following is the treatment of first choice in patients with alloantibodies ?
A. Desmopressin
B. Factor VIII–von Willebrand factor concentrates
C. Recombinant factor VIII
D. Platelet concentrates